Supertake
Illustration for GLP-1 Decade

GLP-1 Decade

whopaulhugh@whopaulhugh

+3.3%

since Oct 8

Practice

The idea

I believe cheaper, more accessible weight-loss drugs are about to reshape how people eat, shop and get treated over the next decade, and that the upside spreads well past the two companies making the drugs. So I split this evenly three ways: the drugmakers and their suppliers, the food and fitness businesses that gain as habits shift, and the healthcare players who manage and pay for these treatments. I lean toward larger, steadier names with a few smaller bets mixed in, and I keep a slice in cash since this is meant to play out over years, not months.

What it owns

  • · , , , , , , 30%
  • · , , , , , , 30%
  • · , , , , , , , 30%
  • Cash10%